Effects of the gonadotrophin releasing hormone in patients with hypothalamic pituitary-gonadal diseases.
D000172:Acromegaly / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy; D013734:Androgen-Insensitivity Syndrome / Q000188:drug therapy; D000856:Anorexia Nervosa / Q000188:drug therapy; D001932:Brain Neoplasms / Q000188:drug therapy; D003397:Craniopharyngioma / Q000188:drug therapy; D003480:Cushing Syndrome / Q000188:drug therapy; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use*; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D007018:Hypopituitarism / Q000188:drug therapy; D007031:Hypothalamus / Q000187:drug effects*; D007713:Klinefelter Syndrome / Q000188:drug therapy; D007775:Lactation Disorders / Q000188:drug therapy; D008297:Male; D010048:Ovarian Cysts / Q000188:drug therapy; D010900:Pituitary Diseases / Q000188:drug therapy*; D010911:Pituitary Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D011629:Puberty, Precocious / Q000188:drug therapy; D014424:Turner Syndrome / Q000188:drug therapy
D007987:Gonadotropin-Releasing Hormone